西地那非治疗先天性心脏病相关肺动脉高压
被引量:3
摘要
按照2003年WHO在意大利威尼斯举办的第3次肺动脉高压专家工作组会议制定的肺动脉高压诊断分类标准,先天性心脏病(congenital heart disease,CHD)相关肺动脉高压(pulmonary arterial hypertension,PAH)属于第一类肺动脉高压,其标准为静息时平均肺动脉压〉25mmHg,运动时平均肺动脉压〉30mmHg。
出处
《中国心血管杂志》
2010年第2期151-153,共3页
Chinese Journal of Cardiovascular Medicine
基金
"十一五"科技支撑计划项目(2006BAI01A08)
参考文献26
-
1Essayan DM. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol,2001,108 :671-680.
-
2Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child,2003,88:827-828.
-
3Maharaj CH, O'Toole D, Lynch T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol,2009,7:34.
-
4Tantini B,Manes A, Fiumana E, et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol.2005.100 : 131-138.
-
5Remillard CV, Yuan JX. TRP channels, CCE, and the pulmonary vascular smooth muscle. Micrecirculation, 2006, 13 : 671-692.
-
6Wang C, Wang J, Zhao L, et al. Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca^2+ entry. J Pharmacol Sci,2008,108:71-78.
-
7Li B, Yang L, Shen J, et al. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation. Anesth Analg,2007,105:1034-1041.
-
8Mikhail GW, Prasad SK, Li W, et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J,2004,25:431-436.
-
9Raposo-Sonnenfeld I, Otero-Gonzalez I, Blanco-Aparicio M, et al. Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Rev Esp Cardiol, 2007,60 : 366- 372.
-
10Chau EM,Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol,2007,120:301-305.
同被引文献14
-
1Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
-
2张玉顺,尹传贵,朱鲜阳,等.结构性心脏病介入治疗新进展[M].西安:世界图书出版公司,2008.318-324.
-
3Galie N, Ghofrani H A, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial nypertension [J]. N Engl JMed,2005,335:2148-2157.
-
4Essayan D M. Cylic nucleotide phosphodieaterases [J]. Allergy Clin Immunol, 2001,108:671-680.
-
5Carroll W D, Dhillon R. Sildenafil as a treatment for pulmo- nary hypertension[J]. Arch Dis Child, 2003,88 : 827-828.
-
6Maharaj C H , O'Toole D, Lynch T, et al. Effects and mech- anisms of action of sildenafil citrale in human chorionic ar- teries [ J]. Reprod Biol Endocrinol, 2009,7 : 34.
-
7Semigran M.Myocardial effects of PDE5 inhibition: more function with lessmass [ J ]. Am Coll Cardiol, 2009,53 : 216- 217.
-
8钟士庆.PGE1与西地那非治疗先天性心脏病手术后肺动脉高压的疗效比较[J].中国妇幼保健,2010,25(25):3662-3663. 被引量:3
-
9王芳.枸橼酸西地那非治疗肺动脉高压35例[J].中国实用医刊,2012,39(1):81-82. 被引量:3
-
10冯宇,莫绪明.西地那非治疗先天性心脏病伴肺动脉高压的研究进展[J].中华临床医师杂志(电子版),2012,6(2):131-133. 被引量:8
引证文献3
-
1王丽娜,杨峰.西地那非片治疗先天性心脏病合并严重肺动脉高压的临床观察[J].河南职工医学院学报,2011,23(4):418-419. 被引量:3
-
2董榆.西地那非治疗先天性心脏病相关肺动脉高压27例临床观察[J].大理学院学报(综合版),2015,14(10):17-19. 被引量:1
-
3强海峰,舒涛,伍源,杨谦,孙勇,赵霞.口服西地那非治疗先天性心脏病手术后肺动脉高压的临床效果观察[J].现代诊断与治疗,2014,25(21):4891-4892. 被引量:1
二级引证文献5
-
1黄梦照,梁东,廖驰林.西地那非治疗先天性心脏病合并肺动脉高压患儿21例临床观察[J].中国医药指南,2012,10(30):117-118. 被引量:1
-
2林仁华.西地那非治疗儿童先天性心脏病合并肺动脉高压临床疗效观察[J].中国实用医药,2015,10(31):135-136. 被引量:2
-
3朱爱红.西地那非对先天性心脏病患儿术后肺动脉高压的影响[J].北方药学,2018,15(8):47-47. 被引量:2
-
4王全义,李红梅.西地那非治疗小儿先天性心脏病合并肺动脉高压的临床疗效分析[J].山西医药杂志,2019,48(9):1092-1095. 被引量:3
-
5程锦,孙闯,薛玉刚.利奥西呱联合西地那非治疗先天性心脏病合并肺动脉高压的临床疗效观察[J].现代医学,2020,48(4):512-515. 被引量:9
-
1荆志成,徐希奇,邓可武.甲状腺疾病与特发性肺动脉高压[J].中华医学信息导报,2004,19(17):15-15.
-
2边静,宋芳.抗CCP抗体和RF联合检测对于类风湿关节炎诊断的意义[J].临床合理用药杂志,2013,6(23):99-100. 被引量:3
-
3宋红梅,魏珉.儿童结缔组织病相关性肺动脉高压的诊断与治疗[J].中华儿科杂志,2008,46(11):847-850. 被引量:1
-
4李楠,王枢传.肺动脉高压的研究进展[J].国际呼吸杂志,2007,27(15):1188-1192. 被引量:5
-
5王秋芬,廖玉华.欧洲心脏病协会2004年肺动脉高压诊断和治疗指南简介[J].临床心血管病杂志,2005,21(7):385-386. 被引量:57
-
6张炜,荆志成.肺动脉高压遗传学研究进展[J].中华心血管病杂志,2007,35(11):1063-1066. 被引量:3
-
7孙彦龙,杨敬平,宋艳红.钙拮抗剂在低氧性肺动脉高压中的治疗作用[J].临床肺科杂志,2009,14(1):88-90. 被引量:2
-
8张颖,刘双,杨京华.肺动脉高压诊断及分类[J].心肺血管病杂志,2008,27(3):191-192. 被引量:15
-
9何华,马长生.心房颤动射频消融威尼斯国际共识——2007解读[J].中国心脏起搏与心电生理杂志,2007,21(3):189-195. 被引量:11
-
10唐洁.4项指标在类风湿关节炎诊断中的作用[J].检验医学与临床,2012,9(1):117-117.